Literature DB >> 24168854

Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation.

Jan-Malte Sinning1, Viktoria Adenauer, Anne-Cathérine Scheer, Sisa Josefina Lema Cachiguango, Alexander Ghanem, Christoph Hammerstingl, Alexander Sedaghat, Cornelius Müller, Mariuca Vasa-Nicotera, Eberhard Grube, Georg Nickenig, Nikos Werner.   

Abstract

AIMS: Acute kidney injury (AKI) is a strong but rather late predictor of mortality after transcatheter aortic valve implantation (TAVI). Early clinically useful markers for the detection of AKI and prediction of outcome are needed in order to control and improve management of periprocedural complications after TAVI. The aim of our study was to assess the predictive value of the Doppler-based renal resistance index (RRI), which correlates inversely with effective renal blood flow and creatinine clearance, for AKI in patients undergoing TAVI and to evaluate its association with paravalvular aortic regurgitation (PAR). METHODS AND
RESULTS: TAVI was performed with the Medtronic CoreValve prosthesis in 132 consecutive high-risk patients (mean logistic EuroSCORE: 30.3±18.2%). RRI, serum creatinine and cystatin C level were determined before, and 4 hrs, 24 hrs, 48 hrs, 72 hrs, and 7 days after TAVI. AKI occurred in 32/132 patients (24.2%). While serum creatinine and cystatin C levels decreased at first after TAVI (also in most patients developing AKI), the RRI increased significantly immediately after the procedure from 0.79±0.09 to 0.87±0.12 in patients developing AKI (p=0.003). A RRI >0.85 predicted post-interventional AKI with a sensitivity of 58% and specificity of 86%, and was superior to the serum creatinine level (p<0.001). In addition, an elevated RRI was significantly related to haemodynamic changes after TAVI and was associated with the occurrence of moderate/severe PAR (p<0.001).
CONCLUSIONS: Measurement of the Doppler-based RRI predicts risk for AKI and increased mortality rates at an early post-procedural time point and is related to the occurrence of more-than-mild paravalvular aortic regurgitation after TAVI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24168854     DOI: 10.4244/EIJV9I11A221

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

Review 1.  Acute kidney injury after transcatheter aortic valve implantation.

Authors:  Maximilian Scherner; Thorsten Wahlers
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  The Association of Aortic Valve Pathology With Renal Resistive Index as a Kidney Injury Biomarker.

Authors:  Benjamin Y Andrew; Anne D Cherry; Jennifer N Hauck; Alina Nicoara; Cory D Maxwell; Ryan M Konoske; Annemarie Thompson; Lakshmi D Kartha; Madhav Swaminathan; Mark Stafford-Smith
Journal:  Ann Thorac Surg       Date:  2018-02-07       Impact factor: 4.330

3.  Intraoperative renal resistive index threshold as an acute kidney injury biomarker.

Authors:  Anne D Cherry; Jennifer N Hauck; Benjamin Y Andrew; Yi-Ju Li; Jamie R Privratsky; Lakshmi D Kartha; Alina Nicoara; Annemarie Thompson; Joseph P Mathew; Mark Stafford-Smith
Journal:  J Clin Anesth       Date:  2019-11-04       Impact factor: 9.452

4.  Network meta-analysis on the comparative effectiveness and safety of transcatheter aortic valve implantation with CoreValve or Sapien devices versus surgical replacement.

Authors:  G Biondi-Zoccai; M Peruzzi; A Abbate; Z M Gertz; U Benedetto; E Tonelli; F D'Ascenzo; A Giordano; P Agostoni; G Frati
Journal:  Heart Lung Vessel       Date:  2014

Review 5.  Acute kidney injury after transcatheter aortic valve replacement in the elderly: outcomes and risk management.

Authors:  Marta Zaleska-Kociecka; Maciej Dabrowski; Janina Stepinska
Journal:  Clin Interv Aging       Date:  2019-01-21       Impact factor: 4.458

Review 6.  Transcatheter Aortic Valve Replacement: a Kidney's Perspective.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Kianoush Kashani
Journal:  J Renal Inj Prev       Date:  2016-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.